Safety concerns hang over new Alzheimer's treatment
Within hours, the world will have a better idea about prospects a new Alzheimer's treatment when Japanese drugmaker Eisai releases late-stage clinical trial results. The big picture: News of a second patient death linked to the drug has dampened expectations and potentially created a more…
#eisai #clinical #science #drug #drugmakereisai #lecanemab #alzheimer #latestageclinical #patient #biogen